IHE ETF: iShares U.S. Pharmaceuticals ETF - Price, Holdings & Analysis
iShares U.S. Pharmaceuticals ETF Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
Frequently Asked Questions About iShares U.S. Pharmaceuticals ETF
What is the current price of IHE?
The latest IHE price is $94.75. The 52-week range is $64.46–$95.60. IHE has returned 41.0% over the past 52 weeks.
What is the expense ratio for IHE?
IHE's annual expense ratio is 0.38%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equitys in the ETF Screener.
Does IHE pay dividends?
Yes, IHE pays a 1.87% dividend yield. The last ex-dividend date was 2026-06-20. View full dividend history in the Dividends section.
What are the top holdings of IHE?
IHE's largest holdings are Johnson & Johnson (22.6%), Eli Lilly and Company (21.5%), Royalty Pharma plc (4.9%) (combined weight: 49.0%). The fund holds 60 total positions. View the complete portfolio breakdown in the Holdings section.
How does IHE compare to similar ETFs?
Compare IHE (0.38% expense ratio, $972M AUM) against similar Equitys using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.